ECHO IQ LIMITED | ASX:EIQ | ABN 48 142 901 353 Financial Statements to 30 June 2026 www.echoiq.ai Echo IQ uses AI-driven technology and proprietary software to improve decision making in cardiology. Corporate directory 30 June Annual Report DIRECTORS Andrew Grover, Executive Chair...
Annual Report to Shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Preliminary Final Report
- Cleansing Notice
- Application for quotation of securities - EIQ
- Convertible note executed with Pro Medicus
- Investor Webinar
Later from EchoIQ
- Appendix 4G and Corporate Governance Statement
- Global healthcare investment leader appointed to Board
- Initial Director's Interest Notice - Scott Wilkin
- Proposed issue of securities - EIQ
- S&P DJI Announces September 2026 Quarterly Rebalance
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ